AKT1 and acute lymphoblastic leukemia: To the best of our knowledge, our findings demonstrate, for the first time, a direct relationship between Nrf2 overexpression and anti-apoptotic protein inhibition, BAD, which in the PI3K-AKT pathway that decreased response to chemotherapeutic response in adult patients with B-ALL.